GUERRA, TOMMASO
GUERRA, TOMMASO
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis
2019-01-01 Guastadisegno, Chiara; Cazzolla, Annamaria; Noviello, Silvia; Tiritiello, Letizia; Guerra, Tommaso; Vacca, Angelo; Racanelli, Vito; Prete, Marcella
Dengue fever in a multiple sclerosis patient taking Ocrelizumab
2021-01-01 Guerra, Tommaso; Bollo, Luca; Trojano, Maria; Iaffaldano, Pietro
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years
2021-01-01 Guerra, Tommaso; Caputo, Francesca; Orlando, Bianca; Paolicelli, Damiano; Trojano, Maria; Iaffaldano, Pietro
Predictors of unemployment status in people with relapsing multiple sclerosis: a single center experience
2022-01-01 Guerra, T.; Pipoli, A.; Viterbo, R. G.; Manghisi, N.; Paolicelli, D.; Iaffaldano, P.; Di Lorenzo, L.
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
2022-01-01 Paolicelli, Damiano; Ruggieri, Maddalena; Manni, Alessia; Gargano, Concetta D; Carleo, Graziana; Palazzo, Claudia; Iaffaldano, Antonio; Bollo, Luca; Guerra, Tommaso; Saracino, Annalisa; Frigeri, Antonio; Iaffaldano, Pietro; Trojano, Maria
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration
2021-01-01 Ferraro, D; Iaffaldano, P; Guerra, T; Inglese, M; Capobianco, M; Brescia Morra, V; Zaffaroni, M; Mirabella, M; Lus, G; Patti, F; Cavalla, P; Cellerino, M; Malucchi, S; Pisano, E; Vitetta, F; Paolicelli, D; Sola, P; Trojano, M
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide
2020-01-01 Bollo, L.; Guerra, T.; Bavaro, D. F.; Monno, L.; Saracino, A.; Angarano, A.; Paolicelli, D; Trojano, M.; Iaffaldano, P
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register
2022-01-01 Iaffaldano, Pietro; Lucisano, Giuseppe; Guerra, Tommaso; Patti, Francesco; Onofrj, Marco; Brescia Morra, Vincenzo; Zaffaroni, Mauro; Pozzilli, Carlo; Cocco, Eleonora; Sola, Patrizia; Salemi, Giuseppe; Inglese, Matilde; Bergamaschi, Roberto; Gasperini, Claudio; Conte, Antonella; Salvetti, Marco; Lus, Giacomo; Maniscalco, Giorgia Teresa; Totaro, Rocco; Vianello, Marika; Granella, Franco; Ferraro, Elisabetta; Aguglia, Umberto; Gatto, Maurizia; Sangalli, Francesca; Chisari, Clara Grazia; De Luca, Giovanna; Carotenuto, Antonio; Baroncini, Damiano; Colombo, Delia; Nica, Mihaela; Paolicelli, Damiano; Comi, Giancarlo; Filippi, Massimo; Amato, Maria Pia; Trojano, Maria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis | 1-gen-2019 | Guastadisegno, Chiara; Cazzolla, Annamaria; Noviello, Silvia; Tiritiello, Letizia; Guerra, Tommaso; Vacca, Angelo; Racanelli, Vito; Prete, Marcella | |
| Dengue fever in a multiple sclerosis patient taking Ocrelizumab | 1-gen-2021 | Guerra, Tommaso; Bollo, Luca; Trojano, Maria; Iaffaldano, Pietro | |
| Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years | 1-gen-2021 | Guerra, Tommaso; Caputo, Francesca; Orlando, Bianca; Paolicelli, Damiano; Trojano, Maria; Iaffaldano, Pietro | |
| Predictors of unemployment status in people with relapsing multiple sclerosis: a single center experience | 1-gen-2022 | Guerra, T.; Pipoli, A.; Viterbo, R. G.; Manghisi, N.; Paolicelli, D.; Iaffaldano, P.; Di Lorenzo, L. | |
| Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients | 1-gen-2022 | Paolicelli, Damiano; Ruggieri, Maddalena; Manni, Alessia; Gargano, Concetta D; Carleo, Graziana; Palazzo, Claudia; Iaffaldano, Antonio; Bollo, Luca; Guerra, Tommaso; Saracino, Annalisa; Frigeri, Antonio; Iaffaldano, Pietro; Trojano, Maria | |
| Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration | 1-gen-2021 | Ferraro, D; Iaffaldano, P; Guerra, T; Inglese, M; Capobianco, M; Brescia Morra, V; Zaffaroni, M; Mirabella, M; Lus, G; Patti, F; Cavalla, P; Cellerino, M; Malucchi, S; Pisano, E; Vitetta, F; Paolicelli, D; Sola, P; Trojano, M | |
| Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide | 1-gen-2020 | Bollo, L.; Guerra, T.; Bavaro, D. F.; Monno, L.; Saracino, A.; Angarano, A.; Paolicelli, D; Trojano, M.; Iaffaldano, P | |
| Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register | 1-gen-2022 | Iaffaldano, Pietro; Lucisano, Giuseppe; Guerra, Tommaso; Patti, Francesco; Onofrj, Marco; Brescia Morra, Vincenzo; Zaffaroni, Mauro; Pozzilli, Carlo; Cocco, Eleonora; Sola, Patrizia; Salemi, Giuseppe; Inglese, Matilde; Bergamaschi, Roberto; Gasperini, Claudio; Conte, Antonella; Salvetti, Marco; Lus, Giacomo; Maniscalco, Giorgia Teresa; Totaro, Rocco; Vianello, Marika; Granella, Franco; Ferraro, Elisabetta; Aguglia, Umberto; Gatto, Maurizia; Sangalli, Francesca; Chisari, Clara Grazia; De Luca, Giovanna; Carotenuto, Antonio; Baroncini, Damiano; Colombo, Delia; Nica, Mihaela; Paolicelli, Damiano; Comi, Giancarlo; Filippi, Massimo; Amato, Maria Pia; Trojano, Maria |